Procurement Summary
Country : Poland
Summary : Delivery of Drugs used in Drug Programs
Deadline : 26 Sep 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 106079273
Document Ref. No. : 501637-2024
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
The detailed description is included in Annex 2.1-2.7 of the Adalimumabum assortment and price specification for the drug program-Treatment of Leśniowski-Crohn B.32 Detailed description of the subject of the contract includes Annex 2.1 to SWZ Natalizumabum to the drug program-treatment of patients with multiple sclerosis B.29 detailed description of the subject Orders are included in Annex 2.2 to SWZ Dimethylis Fumaras - to the drug program - Treatment of multiple sclerosis B.29 The detailed description of the subject of the contract includes Annex 2.3 to SWZ ElTrombopagum - to the drug program - treatment of pediatric patients with chronic immune thrombocytopenia B.98 Detailed description of the subject of the contract includes an attachment 2.4 to SWZ Blinatumomab - a drug used in the drug program - treatment of patients with acute lymphoblastic leukemia B.65 The detailed description of the subject of the contract is included in Annex 2.5 to SWZ Alglucosidasum alpha - a medicine used in the drug program - treatment of pompe disease b.22 The detailed description of the subject of the contract includes the attachment 2.6 to SWZ Toxinum Botulinicum Typum A - for the drug program - Treatment of spasticity in cerebral palsy b.30 Detailed description of the subject of the contract ...
Document Type: Contract Notice
Reference Number: ZP/40/24
Contract Type: supplies
Authority Type: body-pl
Doc Title: Dostawy leków stosowanych w programach lekowych
Dispatch Date: 2024-08-20
Publish Date: 2024-08-21
Submission Date: 2024-09-26
Documents
Tender Notice